Novel therapies in sickle cell disease.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2009, Pages 54-61

  Ataga, Kenneth I ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; BOSENTAN; HEMOGLOBIN F; IMMUNOGLOBULIN; NEW DRUG; NIPRISAN; NITRIC OXIDE; PLANT EXTRACT; SULFONAMIDE;

ACUTE CHEST SYNDROME; BIOSYNTHESIS; BLOOD; CHEMISTRY; CHILD; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ERYTHROCYTE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SICKLE CELL ANEMIA;

ACUTE CHEST SYNDROME; ANEMIA, SICKLE CELL; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; CHILD; DOUBLE-BLIND METHOD; DRUGS, INVESTIGATIONAL; ERYTHROCYTES; FETAL HEMOGLOBIN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; NITRIC OXIDE; PLANT EXTRACTS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SULFONAMIDES;

EID: 77949435188     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2009.1.54     Document Type: Review

References (70)